Inventor · disambiguated record
Evangelos Aktoudianakis
Also filed as: AKTOUDIANAKIS EVANGELOS
16 granted patents·5 pending applications·149 citations·filing 2009–2025
91Inventor score
Files withGILEAD SCIENCES INC21
Top patents by PatentIndex Score
21 records- 0198US9670205B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 6, 2017·100 cites·16 claims
- 0296US10285990B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 14, 2019·11 cites·6 claims
- 0393US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 0491US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0589US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 0689US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 0783US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 0883US10442804B2Compounds for the treatment of hepatitis B virus infectionGILEAD SCIENCES INC·Filed 2018·Granted Oct 15, 2019·4 cites·20 claims
- 0983US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1078US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1177US12377100B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Aug 5, 2025·0 cites·5 claims
- 1277US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 1372US7998950B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2009·Granted Aug 16, 2011·1 cites·17 claims
- 1470US12037342B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·54 claims
- 1562US2019282576A1Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 1660US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 1755US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 1852US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 1948US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2047US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 2139US2017342068A1Compounds for the treatment of hepatitis b virus infectionGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Evangelos Aktoudianakis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →